Yu, Ming-Lung

Publishing since 1988 (Dinosaur)

Has published 132 publications in 23 years

Number of publications published per year by Yu, Ming-Lung. (Source : PubMed)

Distribution of publications types for Yu, Ming-Lung. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Dai CY, Huang JF, Hsieh MY, Chuang WL, Yu ML. Insulin resistance, viral load and response to peginterferon and ribavirin in patients with chronic hepatitis C virus infection.  Gut  2010;59;3  
•  Huang CF, Yang JF, Dai CY, Huang JF, Hou NJ, Hsieh MY, Lin ZY, Chen SC, Hsieh MY, Wang LY, Chang WY, Chuang WL, Yu ML. Efficacy and safety of pegylated interferon combined with ribavirin for the treatment of older patients with chronic hepatitis C.  J. Infect. Dis.  2010;201;5  
•  Hsieh MH, Lin WY, Dai CY, Huang JF, Huang CK, Chien HH, Wang CL, Chung WL, Wu JR, Chen ER, Ho CK, Yu ML. Intestinal parasitic infection detected by stool examination in foreign laborers in Kaohsiung.  Kaohsiung J. Med. Sci.  2010;26;3  
•  Dai CY, Ho CK, Huang JF, Hsieh MY, Hou NJ, Lin ZY, Chen SC, Hsieh MY, Wang LY, Chang WY, Yu ML, Chuang WL. Hepatitis C virus viremia and low platelet count: a study in a hepatitis B & C endemic area in Taiwan.  J. Hepatol.  2010;52;2  
•  Wu KT, Yang JF, Chuang WL, Yu ML. Insulin resistance predicts rapid virological response in non-diabetic, non-cirrhotic genotype 1 HCV patients treated with peginterferon alpha-2b plus ribavirin: some issues.  J. Hepatol.  2010;52;2  
•  Dai CY, Chuang WL, Hsieh MY, Huang JF, Lin YY, Chu PY, Hou NJ, Lin ZY, Chen SC, Hsieh MY, Wang LY, Yu ML. Human leukocyte antigen alleles and the response to pegylated interferon/ribavirin therapy in chronic hepatitis C patients.  Antiviral Res.  2010;85;2  
•  Lin HY, Li SS, Yu ML, Hsiao PJ, Hsieh MC, Lin KD, Wang CL, Wang TN, Shin SJ. Small ubiquitin-like modifier-4 Met55Val polymorphism is associated with glycemic control of type 2 diabetes mellitus in Taiwan.  J. Endocrinol. Invest.  2009  
•  Jeng JE, Tsai HR, Chuang LY, Tsai JF, Lin ZY, Hsieh MY, Chen SC, Chuang WL, Wang LY, Yu ML, Dai CY, Chang JG. Independent and additive interactive effects among tumor necrosis factor-alpha polymorphisms, substance use habits, and chronic hepatitis B and hepatitis C virus infection on risk for hepatocellular carcinoma.  Medicine (Baltimore)  2009;88;6  
•  Hsieh MH, Ho CK, Hou NJ, Hsieh MY, Lin WY, Yang JF, Chiu CC, Huang JF, Chang NC, Wang CL, Dai CY, Chuang WL, Yu ML. Abnormal liver function test results are related to metabolic syndrome and BMI in Taiwanese adults without chronic hepatitis B or C.  Int J Obes (Lond)  2009;33;11  
•  Dai CY, Huang CF, Chuang WL, Huang JF, Yu ML. The substantial role of initial ribavirin dose on the response to peginterferon alpha/ribavirin therapy in patients with genotype 1b chronic hepatitis C.  Am. J. Gastroenterol.  2009;104;9  

[ See timeline ] [ See all publications ]